PATENT CLAIM ANALYSIS

Application Number: 15869250
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["548", "356100"]

Abstract:
Provided is an agent for the treatment or prophylaxis of inflammatory diseases, allergic diseases, autoimmune diseases, transplant rejection or the like. A compound represented by the following formula [I] or a pharmaceutically acceptable salt thereof, or a solvate thereof: wherein each symbol is as described in the specification.

Claim (Index 28):
A compound of formula [1] wherein R 1  is\n (1) a hydrogen atom, \n (2) a hydroxy group, or \n (3) a C 1-6  alkoxy group optionally substituted by C 6-10 aryl group(s); \n R 2  and R 3  are the same or different and each is\n a C 1-6  alkyl group optionally substituted by 1 to 3 substituents selected from\n (a) a hydroxy group, and \n (b) a C 1-6  alkoxy group; and \n \n R 9  is an amino-protecting group selected from the group consisting of a tert-butoxycarbonyl group, an ethoxycarbonyl group, a trityl group, a tetrahydropyranyl group, a methoxymethyl group, a 2-(trimethylsilyl)ethoxymethyl group, and a p-toluenesulfonyl group.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 86.0
- Lexical Diversity: 1.35714
- Patent Class: 548.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12954438', '10645934', '14902309', '12065607', '15510225']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8370171903608072
- 35 USC 102 Novelty (BERT): 0.6260382209279
- Combined Prediction Score: 0.8159192934175166
- Mean Citation Score: 426.174096
- Max Citation Score: 588.39124
- Similarity Product: 549.6284105402565

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test